Ocumetics Technology Corp.

TSXV:OTC Stock Report

Market Cap: CA$38.3m

Ocumetics Technology Valuation

Is OTC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OTC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate OTC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate OTC's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OTC?

Key metric: As OTC is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for OTC. This is calculated by dividing OTC's market cap by their current book value.
What is OTC's PB Ratio?
PB Ratio-40.2x
Book-CA$954.23k
Market CapCA$38.33m

Price to Book Ratio vs Peers

How does OTC's PB Ratio compare to its peers?

The above table shows the PB ratio for OTC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average4.9x
ZEN Zentek
9.6xn/aCA$178.0m
NSCI Nanalysis Scientific
1.7xn/aCA$43.0m
ASG Aurora Spine
5xn/aCA$33.3m
PINK Perimeter Medical Imaging AI
3.4x-10.2%CA$56.0m
OTC Ocumetics Technology
n/an/aCA$38.3m

Price-To-Book vs Peers: OTC has negative equity and a Price-To-Book Ratio (-40.2x) compared to the peer average (4.9x).

Price to Book Ratio vs Industry

How does OTC's PB Ratio compare vs other companies in the CA Medical Equipment Industry?

2 CompaniesPrice / BookEstimated GrowthMarket Cap
SCYB Scryb
0.4xn/aUS$3.44m
ASEP ASEP Medical Holdings
0.3xn/aUS$3.02m
No more companies available in this PB range
OTC is unprofitableIndustry Avg. 2.6xNo. of Companies2PB0246810+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: OTC has negative equity and a Price-To-Book Ratio (-40.2x) compared to the North American Medical Equipment industry average (2.6x).

Price to Book Ratio vs Fair Ratio

What is OTC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OTC PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio-40.2x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate OTC's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

7D

6.3%

1Y

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

DR

CA$15.55

7D

3.2%

1Y

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

7D

-37.5%

1Y

-28.6%